Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.

Exelixis tops Q4 estimates with new buybacks boosting momentum. Cabometyx sales climb and zanzalintinib advances toward FDA ...

BlueLinx Holdings Inc. (NYSE: BXC), a leading U.S. wholesale distributor of building products, will issue fourth quarter and full year 2025 financial results after the market closes on Tuesday, ...

MILAN (AP) — One of the recurring issues during the opening week of the figure skating program at the Milan Cortina Olympics has been copyright problems, which have forced some athletes to scramble ...

Ahead of the project's February release, the rapper revealed more info on the anticipated LP in a new 'Booman' documentary ...